Select Publications

Publications discussed by Dr Ellis

Cobleigh MA et al. A Phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. Semin Oncol 2004;22(1):23-30. Semin Oncol. 2003 Oct;30(5 Suppl 16):117-24. Abstract

Goldberg RM et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Onco 2004;22(1):23-30. Abstract

Miller KD et al. Phase III trial of capecitabine (Xeloda®) plus bevacizumab (AvastinT) versus capecitabine alone in women with metastatic breast cancer (MBC) previously treated with an anthracycline and a taxane. Breast Cancer Res Treat 2002;76(Suppl 1);Abstract 36

Morgan B et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: Results from two Phase I studies. Br J Cancer 2003;21(21):3955-64. Abstract

Wildiers H et al. Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11. Br J Cancer 2003;88(12):1979-86. Abstract